Journal of Cancer

open access Global reach, higher impact

Review Emerging Oncolytic Viruses: Beyond Adenoviruses and Herpes Simplex Virus Santosh Chokkakula, Cheng-liang Yin, Bing Yang, Siomui Chong, Balaji Pathakumari, Yi-quan Zhang, Pangi Vijaya Nirmala, Khin Wee Lai, Bommireddy Naveen, Quan Tang J. Cancer 2026; 17(6): 1229-1247. doi:10.7150/jca.134550 Full text PDF

Research Paper GALNT14-rs9679162 Genotypes Predict Post-immunotherapy Side Effect and Survival in Patients with Hepatitis B Virus-related Hepatocellular Carcinoma Po-Ting Lin, Wei Teng, Wei-Ting Chen, Yu-De Chu, Chung-Wei Su, Yi-Chung Hsieh, Chen-Chun Lin, Yung-Chang Lin, Chun-Yen Lin, Chau-Ting Yeh, Shi-Ming Lin J. Cancer 2026; 17(6): 1220-1228. doi:10.7150/jca.133473 Full text PDF

Review Exosomes in Cancer Biology: Emerging Biomarkers and Therapeutic Targets Marriam Ahmed, Chieh-Wei Chang, Sundas Ijaz, Abdul Qadeer, Khalid J. Alzahrani, Khalaf F. Alsharif, Fuad M. Alzahrani, Abdulwahab Abuderman, Chien-Chin Chen, Shahid Hussain J. Cancer 2026; 17(6): 1206-1219. doi:10.7150/jca.132498 Full text PDF

Research Paper Assessing the Association Between Genetic Variants in ACE, SOD1, and PER3 and their Role in Breast Cancer Risk among Jordanian Women Laith N. AL-Eitan, Fouad A. Almomani, Mohammed S. Alorjani, Maryam K. Alasmar, Haneen O. Ali, Mansour A. Alghamdi J. Cancer 2026; 17(6): 1195-1205. doi:10.7150/jca.133243 Full text PDF

Research Paper CellVizio^® System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons Paul Zarogoulidis, Wolfgang Hofenforst-Schwidt, Haidong Huang, Stavros Tryfon, Yifei Zhang, Guoren Ma, Kyriakos Amarantidis, Elena Maragouli, Vasilis Papadopoulos, Eleni-Isidora Perdikouri, Vagelis Voulgaris, Lutz Freitag, Chrysoula Margioula-Siarkou, Theodora Tsiouda, Paschalis Ntolios, Stamatis Petousis, Konstantina Triantafylopoulou, Kosmas Tsakiridis, Nikolaos Courcoutsakis, Sofia Baka, Dimitris Baloukas, Paschalis Steiropoulos, Bojan Zaric, Xiaping Shen J. Cancer 2026; 17(6): 1187-1194. doi:10.7150/jca.136122 Full text PDF

Review Development of nasopharyngeal carcinoma target delineation: from two-dimensional radiotherapy to adaptive precision radiotherapy Xiaojing Yang, Lijun Liu, Huicai Zhang, Hanru Ren, Jie Fu J. Cancer 2026; 17(6): 1179-1186. doi:10.7150/jca.125480 Full text PDF

More ...

Issue 6; 2026

Indexed in PubMed and SCI expanded; full texts in Europe PMC. ...

CellVizio^® System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons

Introduction: The best tissue sample is still very important for the diagnosis of mesothorax lymphadenopathy. In the past 20 years endobronchial ultrasound (EBUS) has been used efficiently in most cases of primary lung cancer disease or metastatic disease. Several new type of needles have been created such 19G, 18G and hybrid biopsies with cryoprobes. Rapid on-site evaluation (ROSE) is used as an additional initial diagnostic tool. Confocal microscopy ...

Development of nasopharyngeal carcinoma target delineation: from two-dimensional radiotherapy to adaptive precision radiotherapy

Nasopharyngeal carcinoma (NPC) is mainly treated with radiotherapy. With the advancements of imaging and radiotherapy techniques, the delineation of NPC target areas has evolved from empirical field setting in the two-dimensional era to three-dimensional conformal radiotherapy (3D-CRT), intensity modulated radiotherapy (IMRT), and image-guided adaptive radiotherapy (ART), significantly improving treatment accuracy and safety. This review systematically ...